Melatonin ameliorates arsenic‐induced cardiotoxicity through the regulation of the Sirt1/Nrf2 pathway in rats
BioFactors · 2023
DOI: 10.1002/biof.1934 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2023. Verfasst von Fatemeh Yarmohammadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Melatonin, Arsenic, MicroRNAs. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Chronic arsenic (As) exposure, mainly as a result of drinking contaminated water, is associated with cardiovascular diseases. Mitochondrial dysfunction, oxidative stress, inflammation, apoptosis, and autophagy have been suggested as the molecular etiology of As cardiotoxicity. Melatonin (Mel) is a powerful antioxidant. Mel improves diabetic cardiomyopathy, cardiac remodeling, and heart failure. Following pre‐treatment with Mel (10, 20, or 30 mg/kg/day i.p.), rats were orally gavaged with As (15 mg/kg/day) for 28 days. Electrocardiographic findings showed that Mel decreased the As‐mediated QT interval prolongation. The effects of As on cardiac levels of glutathione (GSH) and malondialdehyde (MDA) were reversed by Mel pretreatment. Mel also modulated the Sirt1 and Nrf2 expressions promoted by As. Mel down‐regulated autophagy markers such as Beclin‐1 expression and the LC3‐II/I ratio. Moreover, the cardiac expression of cleaved‐caspase‐3 and Bax/Bcl‐2 ratio was decreased by Mel pretreatment. Reduced expression of miR‐34a and miR‐144 by As were reversed by Mel. The histopathological changes of cardiac injury associated with As exposure was moderated by Mel. Mel may improve As‐induced cardiac dysfunction through anti‐oxidative, anti‐apoptotic, and anti‐autophagic mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
- Department of Cell Systems and Anatomy, UT Health, Long School of Medicine, San Antonio, Texas, USA.
ORCID-Profile: Soghra Mehri, Gholamreza Karimi
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Yarmohammadi, F., Barangi, S., Aghaee-Bakhtiari, S. H., Hosseinzadeh, H., Moosavi, Z., Reiter, R. J., Hayes, A. W., Mehri, S., & Karimi, G. (2023). Melatonin ameliorates arsenic‐induced cardiotoxicity through the regulation of the Sirt1/Nrf2 pathway in rats. BioFactors. https://doi.org/10.1002/biof.1934
Vancouver
Yarmohammadi F, Barangi S, Aghaee-Bakhtiari SH, Hosseinzadeh H, Moosavi Z, Reiter RJ, et al. Melatonin ameliorates arsenic‐induced cardiotoxicity through the regulation of the Sirt1/Nrf2 pathway in rats. BioFactors. 2023. doi:10.1002/biof.1934
BibTeX
@article{Yarmohammadi2023,
author = {Yarmohammadi, Fatemeh and Barangi, Samira and Aghaee-Bakhtiari, Seyed Hamid and Hosseinzadeh, Hossein and Moosavi, Zahra and Reiter, Russel J and Hayes, A Wallace and Mehri, Soghra and Karimi, Gholamreza},
title = {Melatonin ameliorates arsenic‐induced cardiotoxicity through the regulation of the Sirt1/Nrf2 pathway in rats},
journal = {BioFactors},
year = {2023},
doi = {10.1002/biof.1934}
}
EUVIMED